Hanu Tyagi

Hanu Tyagi

PhD Candidate
Supply Chain & Operations

Contact

  4-219 CSOM

Education:

  • Ph.D. 2024 (Expected)
    Supply Chain and Operations, Carlson School of Management, University of Minnesota - Twin Cities
  • Post-Graduate Programme in Management 2013
    Management, Indian School of Business, Hyderabad (India)
  • Bachelor of Technology 2008
    Mechanical Engineering, National Institute of Technology, Warangal (India)

Expertise:

  • Empirical Pharmaceutical Operations
  • Innovation & New product development
  • Shortages and stockouts
  • Supply chain transparency

Biography

I am a fifth-year Ph.D. candidate in the Supply Chain and Operations department at the Carlson School of Management, University of Minnesota. I study tensions between operational outcomes in pharmaceutical supply chains such as novelty, quality and safety, availability, and equity and inclusion. In my dissertation, I examine how transparency inhibits drug novelty (essay 1), expedited approvals impact drug safety (essay 2), and quality failures impact drug availability (essay 3). I compile unique datasets and use empirical research methods to generate insights for operations management theory, practice, and policymakers in the pharmaceutical industry.

Before joining the Ph.D. program, I worked as a Research Associate at the Indian School of Business, Hyderabad (India). Before entering academia, I worked as a management consultant at EY-Parthenon (Dubai, UAE) and ZS Associates (Pune, India). I also worked in the management trainee program at Ranbaxy Labs. Ltd (Gurgaon, India). I have a Post-Graduate Programme in Management from the Indian School of Business, Hyderabad (India), and a Bachelor of Technology from the National Institute of Technology, Warangal (India).

On the personal front, I am a traveler, a hiking/trekking enthusiast, and an open-water scuba diver. I am also an avid music lover who is learning Hindustani classical singing.

Selected Works & Activities

  • Journal Articles
    Deo, S., H. Tyagi, C. Chatterjee, H. Molakapuri. 2019. Did India's price control policy for coronary stents create unintended consequences? Social Science & Medicine 246, 112737
  • Journal Articles
    H. Tyagi, M. Sabharwal, N. Dixit, A. Pal, S. Deo. 2020. Leveraging providers' preferences to customize instructional content: A retrospective analysis of a mobile phone-based intervention. JMIR mHealth and uHealth 8 (3), e15998
  • Conference Proceedings
    Tyagi, H., Hermosilla, M., & Shah, R. (2023). How does Transparency Impact Technological Novelty? Evidence from Large Pharmaceutical Firms. In Academy of Management Proceedings (Vol. 2023, No. 1, p. 13909). Briarcliff Manor, NY: Academy of Management
  • Conference Proceedings
    V Heitlage, JF Farley, R Shah, H Tyagi, D Stenehjem. 2022. EPH138 Post-Marketing Adverse Events of Oncology Medications with Breakthrough Therapy Designation Correlated with Time on Market and Market Share. Value in Health 25 (7), S460

Edit This Page

Log in to Edit
Only select this option if you already have access to a Carlson School Drupal account.